Chemring Plc shares rose 1.8% to 494.2p after the company confirmed two new contract awards from the US government worth a combined $345 million, moves that restart activity at its previously closed Alloy Surfaces Company (ASC) decoy facility in Philadelphia.
The larger of the awards is a $300 million indefinite-delivery/indefinite-quantity (IDIQ) contract modification granted under the Defense Production Act. That contract covers the supply of pyrophoric airborne decoys and carries guaranteed minimum annual orders of $35 million for each of the first three years. In addition, Chemring received a separate $45 million Other Transaction Authority (OTA) package intended to finance the restart of manufacturing operations at ASC and to transfer ASC’s intellectual property rights to the US government.
Management had previously closed the Alloy Surfaces unit after a sustained fall in Pentagon demand for special-material pyrophoric decoys, and the company had publicly treated the business as a potential discontinued operation that might be sold or otherwise disposed of. The new contract awards reverse that trajectory by reactivating the unit and securing a stream of government work tied to the provision of this class of decoy.
Company executives have described ASC as NATO’s only production capability for this particular type of decoy, a vulnerability that investors highlighted as a notable risk following Chemring’s H1 2026 results. The latest contracts directly address that investor concern by restoring production capability and by providing multi-year visibility for the Countermeasures & Energetics segment.
The broader market provided modest assistance to the share move. The FTSE 250, of which Chemring is a constituent, edged higher during the session after recovering from a prior day marked by a global technology-led sell-off and softer UK PMI readings. The UK defence sector more generally continues to benefit from heightened geopolitical tensions and increases in NATO member spending commitments, factors cited as supportive of Chemring’s record order book of GBP 1.4 billion.
Together, the two awards remove a material strategic uncertainty, add contracted revenue visibility over multiple years for the countermeasures business, and strengthen the case for investors at a time when the stock trades well below its 52-week high of 614p. Those effects were sufficient to attract buyers and lift the share price on the announcement day.
What this means
- The $300 million IDIQ modification secures a baseline level of orders for pyrophoric airborne decoys through guaranteed minimum spend commitments in the early years.
- The separate $45 million OTA funds the restart of ASC’s manufacturing capability and transfers its intellectual property rights to the US government, enabling the plant’s reactivation.
- The awards address a previously disclosed risk concerning NATO capability and a shuttered production line, contributing to renewed investor confidence despite the stock remaining below its 52-week peak.
Market context
The contracts arrive against a market backdrop in which defence-sector demand has been underpinned by geopolitical tensions and rising NATO spending commitments. Chemring’s record order book of GBP 1.4 billion reflects that environment and helps explain why the contract package was viewed positively by the market.